Find a Clinic Near You And Get Started Today


You are here

Success of Essure®Micro-inserts in the Treatment of Hydrosalpinx Prior to IVF and FET

Status message

Active context: desktop
Monday, November 1, 2010
Treatment of Hydrosalpinx

The objective of this study was to investigate pregnancy outcomes in women with hydrosalpinges treated with Essure® micro-inserts prior to IVF and FET.
One patient (age 40) underwent four IVF cycles; the first two cycles were Age Parity D3 FSH AFC IVF cycles FET Outcome.

The researchers found that Essure placement for hydrosalpinx prior to IVF-ET results in excellent pregnancy rates and outcomes. Four out of six patients conceived (66.6 percent pregnancy rate). And three out of six patients delivered (50 percent live birth rate), with no pregnancy complications. The mean age was 37.5 years old.

Placement of the Essure micro-inserts in patients with hydrosalpinges provides a minimally invasive option for proximal tubal occlusion prior to IVF and FET, and appears to result in excellent pregnancy rates and outcomes. There were no complications related to Essure.

To read the full report, click on the document below.

White Paper File (doc, pdf): 

Add new comment

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
By submitting this form, you accept the Mollom privacy policy.